To test this, we stably overexpressed NME1 in two highly invasive and metastatic human breast carcinoma cell lines, MDA-MB-435 and MDA-MB-231T, to determine its effects on the EMT phenotype. This evidence concerns the gene NME1 and breast carcinoma.